...
首页> 外文期刊>Journal of applied clinical medical physics / >Monte Carlo characterization of biocompatible beta‐emitting glass seed incorporated with the radionuclide as a SPECT marker for brachytherapy applications
【24h】

Monte Carlo characterization of biocompatible beta‐emitting glass seed incorporated with the radionuclide as a SPECT marker for brachytherapy applications

机译:蒙特卡洛表征结合放射性核素作为SPECT标记物的生物相容性β发射玻璃种子的近距离放射治疗应用

获取原文

摘要

A glass seed consisting of the ‐emitting radionuclide incorporated with radionuclide as SPECT marker is proposed for potential application in brachytherapy in order to reduce the undesirable dose to healthy adjacent organs. The aim of this work is to determine the dosimetric characteristics, as suggested in the AAPM TG‐60/TG‐149 reports, for this seed using Monte Carlo simulation. Monte Carlo codes MCNP5, EGSnrc, and FLUKA were used to calculate the absorbed dose distribution around the seed. Dosimetric parameters, such as reference absorbed dose rate, radial dose function, and one‐dimensional (1D) and two‐dimensional (2D) anisotropy functions, were obtained. The computational results from these three codes are in agreement within 5.4% difference on average. The absorbed dose rate at the reference point was estimated to be 5.01 cGy and self absorption of YAS glass seed amounted to 30.51%. The results showed that, with thermal neutron bombardment of 5 hours in a typical flux, sufficient activity for applications in brachytherapy may be achieved. With a 5 mCi initial activity, the total dose of a YAS glass seed was estimated to be 1.38 Gy at 1.0 cm from the seed center. Comparing with gamma emitting seeds, the seed could reduce undesirable doses to adjacent organs, because of the rapid dose falloff of beta ray. Because of the high value of 5.5 mm, fewer number of seeds will be required for an interstitial brachytherapy treatment using permanent implant, in comparison with other beta‐emitting seeds. The results would be helpful in the development of the radioactive implants using glass seeds for the brachytherapy treatment. PACS numbers: 87.53.Jw, 87.56.bg
机译:提出了一种由发射核素与放射性核素作为SPECT标记物结合而成的玻璃种子,有望在近距离放射治疗中应用,以减少对健康邻近器官的不良剂量。这项工作的目的是使用蒙特卡罗模拟方法确定该种子的AAPM TG-60 / TG-149报告中建议的剂量特性。蒙特卡罗代码MCNP5,EGSnrc和FLUKA用于计算种子周围的吸收剂量分布。获得了剂量学参数,例如参考吸收剂量率,径向剂量函数以及一维(1D)和二维(2D)各向异性函数。这三个代码的计算结果平均相差5.4%以内。在参考点的吸收剂量率估计为5.01 cGy,YAS玻璃种子的自吸收率为30.51%。结果表明,以典型的通量对中子进行5个小时的热中子轰击,可以实现在近距离放射治疗中的足够活性。初始活性为5 mCi,在离种子中心1.0 cm处,YAS玻璃种子的总剂量估计为1.38 Gy。与发射伽马射线的种子相比,由于β射线剂量的快速下降,种子可以减少向邻近器官的不希望有的剂量。由于5.5 mm的高价值,与其他发射β的种子相比,使用永久性植入物进行间隙近距离放射治疗所需的种子数量更少。该结果将有助于使用玻璃种子进行近距离放射治疗的放射性植入物的开发。 PACS编号:87.53.Jw,87.56.bg

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号